Esperion Therapeutics
ESPR
$2.30
Share price
5.50%
Change (1 day)
35.29%
Change (1 year)
Categories
Market capitalization of Esperion Therapeutics (ESPR)
Market cap: $0.43 Billion
As of May 2024 Esperion Therapeutics has a market cap of $0.43 Billion. This makes Esperion Therapeutics the world's 6192th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Esperion Therapeutics from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.43 B | 28.16% |
| 2023 | $0.34 B | -25.93% |
| 2022 | $0.45 B | 50.75% |
| 2021 | $0.30 B | -54.81% |
| 2020 | $0.67 B | -58.91% |
| 2019 | $1.63 B | 32.88% |
| 2018 | $1.23 B | -28.46% |
| 2017 | $1.72 B | 510.84% |
| 2016 | $0.28 B | -43.66% |
| 2015 | $0.50 B | -39.08% |
| 2014 | $0.82 B | 290.3% |
| 2013 | $0.21 B |
End of Day market cap according to different sources
On May 15th, 2024 the market cap of Esperion Therapeutics was reported to be:
$0.44 Billion
$0.44 Billion
$0.43 Billion
$0.43 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $163.31 B | 37,377.48% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $107.78 B | 24,635.07% | 🇺🇸 USA |
 Ultragenyx RARE | $3.41 B | 684.48% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.70 B | 60.94% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $2.86 B | 556.62% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $15.26 B | 3,403.40% | 🇺🇸 USA |